ARTICLE | Clinical News
Theratope: Completed Phase III study enrollment
March 12, 2001 8:00 AM UTC
Biomira Inc. (TSE:BRA; BIOM), Edmonton, Alberta Product: Theratope Business: Cancer Therapeutic category: Immune stimulation Target: STn Description: Carbohydrate cancer vaccine containing synthetic ...